• Explore /
  • Poster
  • / Genomic sequencing for bladder urothelial carcinoma and its clinical implications for immunotherapy.

Genomic sequencing for bladder urothelial carcinoma and its clinical implications for immunotherapy.

Abstract Poster

Authors

null

Ryul Kim

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Ryul Kim , Jeeyun Lee , Ghee Young Kwon , Jung Yong Hong , Byong Chang Jeong , Se Hoon Park

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 551)

DOI

10.1200/JCO.2022.40.6_suppl.551

Abstract #

551

Poster Bd #

J9

Abstract Disclosures

Similar Posters

First Author: Changsong QI

First Author: Nikhil Pramod

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Beyond CPS for PD-L1 scoring: Genetic alterations that impact efficacy of immunotherapy in hepatocellular carcinoma (HCC).

Beyond CPS for PD-L1 scoring: Genetic alterations that impact efficacy of immunotherapy in hepatocellular carcinoma (HCC).

First Author: Emil Lou

First Author: Sarah Sammons